Back to dashboard
CommercialAdministrativeLow impact

08.00.51m, Enzyme Replacement for the Treatment of Gaucher's Disease

Independence Blue Cross·Endocrinology, Hematology, Oncology +1 more·Medical Policy
Effective date
Mar 4, 2026
We identified it
Jun 19, 2026
Days to comply
—

Summary

This is a reissue of the existing policy for enzyme replacement therapy for Gaucher's Disease treatment. The policy content remains unchanged from the previous version, with the reissue effective March 4, 2026.

Action Required

Action needed
No immediate action required. This is a policy reissue with no content changes. Billing team should continue following existing procedures for Gaucher's Disease enzyme replacement therapy claims.

Related policy hubs